Home › Therapeutic areas › Neurology › Migraine
Migraine (3 companies)
Companies with an active program in Migraine.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics | Neurology Rare | 1 | Approved | $6.96B | 15 |
| EVMN | Evommune | DermatologyImmunology+1 | 1 | Phase 2 | $241M | 6 |
| RAPP | Rapport Therapeutics | Neurology | 1 | Phase 3 | $1.45B | 10 |
No companies match.